Barth Hoogstraten
- Oncology top 0.2%
- Pulmonary and Respiratory Medicine top 0.5%
- Surgery top 2%
- Molecular Biology top 5%
- Pathology and Forensic Medicine top 1%
- Co-authors
- A. B. MillerM. StaquetAshley E. WinklerSaul E. RivkinDavid H. HuffmanSuk Han WanDaniel L. AzarnoffRobert M. OʼBryan
- Topics
- Cancer Treatment and Pharmacology (16 papers)Acute Lymphoblastic Leukemia research (10 papers)Breast Cancer Treatment Studies (9 papers)
- Partner nations
- United StatesEgyptCanada
In The Last Decade
Barth Hoogstraten
77 papers receiving 8.9k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Oncology 4.9k
- Pulmonary and Respiratory Medicine 3.0k
- Surgery 1.6k
- Molecular Biology 1.5k
- Pathology and Forensic Medicine 1.2k
Countries citing papers authored by Barth Hoogstraten
This map shows the geographic impact of Barth Hoogstraten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barth Hoogstraten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barth Hoogstraten more than expected).
Fields of papers citing papers by Barth Hoogstraten
This network shows the impact of papers produced by Barth Hoogstraten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barth Hoogstraten. The network helps show where Barth Hoogstraten may publish in the future.
Co-authorship network of co-authors of Barth Hoogstraten
This figure shows the co-authorship network connecting the top 25 collaborators of Barth Hoogstraten. A scholar is included among the top collaborators of Barth Hoogstraten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barth Hoogstraten. Barth Hoogstraten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 22 | |
| 2 | Continuous infusion of interleukin-2 and cyclophosphamide as treatment of advanced cancers: a National Biotherapy Study Group Trial. | 5 |
| 3 | 3 | |
| 4 | 6 | |
| 5 | 58 | |
| 6 | Phase II trial of dianhydrogalactitol in advanced renal cell carcinoma: a Southwest Oncology Group study. | 1 |
| 7 | 37 | |
| 8 | Tamoxifen and oophorectomy in the treatment of recurrent breast cancer: a Southwest Oncology Group Study. | 27 |
| 9 | Reporting results of cancer treatmentbreakdown → | 6801 |
| 10 | Growth suppression of human leukemic cells in vitro by L-ascorbic acid. | 68 |
| 11 | 1,2:5,6-Dianhydrogalactitol in advanced breast cancer. | 2 |
| 12 | Pancreatic cancer treated with carmustine, fluorouracil, and spironolactone: a randomized study. | 6 |
| 13 | 300 | |
| 14 | 7 | |
| 15 | Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. | 114 |
| 16 | 89 | |
| 17 | Adriamycin (NSC-123127) plus 5-fluorouracil (NSC-19893): a phase I study. | 1 |
| 18 | 22 | |
| 19 | Intermittent therapy with 6-mercaptopurine (NSC-755) and methotrexate (NSC-740) given intravenously to adults with acute leukemia. | 3 |
| 20 | Cyclophosphamide (cytoxan) in acute leukemia, preliminary report. | 4 |
About Barth Hoogstraten
Barth Hoogstraten is a scholar working on Oncology, Microbiology and Hematology, having authored 79 papers that have together received 9.5k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (16 papers), Acute Lymphoblastic Leukemia research (10 papers) and Breast Cancer Treatment Studies (9 papers). The work is most often cited by research in Oncology (4.9k citations), Pulmonary and Respiratory Medicine (3.0k citations) and Otorhinolaryngology (371 citations). Barth Hoogstraten has collaborated with scholars based in United States, Egypt and Canada. Frequent co-authors include A. B. Miller, M. Staquet, Ashley E. Winkler, Saul E. Rivkin, David H. Huffman, Suk Han Wan, Daniel L. Azarnoff, Robert M. OʼBryan, Laurence H. Baker and S P Balcerzak. Their work appears in journals such as JAMA, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.